Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03596801
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT06942299
What this trial is testing

AK0529 in Adults Patients Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 25
Large-scale testing (Phase 3)Study completedNCT05045144
What this trial is testing

A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,586
Not applicableStudy completedNCT01155193
What this trial is testing

Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany

Who this might be right for
Respiratory Syncytial Virus Infections
AbbVie (prior sponsor, Abbott) 30,804
Testing effectiveness (Phase 2)Study completedNCT05547087
What this trial is testing

A Dose Finding Study of VN-0200

Who this might be right for
Respiratory Syncytial Virus Infections
Daiichi Sankyo 342
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712380
What this trial is testing

A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Large-scale testing (Phase 3)Study completedNCT02325791
What this trial is testing

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Regeneron Pharmaceuticals 1,177
Early research (Phase 1)Study completedNCT04914520
What this trial is testing

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

Who this might be right for
Respiratory Syncytial Virus Infections
Daiichi Sankyo Co., Ltd. 48
Early research (Phase 1)Study completedNCT04871724
What this trial is testing

Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 24
Large-scale testing (Phase 3)Study completedNCT06473519
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 453
Testing effectiveness (Phase 2)Study completedNCT04785612
What this trial is testing

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Hvivo 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Large-scale testing (Phase 3)Study completedNCT04424316
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Who this might be right for
Respiratory Tract Infection
Pfizer 14,727
Testing effectiveness (Phase 2)Study completedNCT02094365
What this trial is testing

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 62
Not applicableStudy completedNCT05727202
What this trial is testing

Project STARFISH - PRJ0002679

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more
Thermo Fisher Scientific, Inc 1,909
Not applicableStudy completedNCT01297504
What this trial is testing

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 464
Early research (Phase 1)Study completedNCT05788237
What this trial is testing

Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults

Who this might be right for
Healthy
Pfizer 508
Early research (Phase 1)UnknownNCT04798001
What this trial is testing

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Who this might be right for
Covid19
Meissa Vaccines, Inc. 130
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation